- ►oxfordjournals.org R Ramasamy, SJ Vannucci, SSD Yan, K Herold, SF … - Glycobiology, 2005 - Soc Glycobiology The products of nonenzymatic glycation and oxidation of proteins and lipids, the advanced glycation
end products (AGEs), accumulate in a wide variety of environments. AGEs may be generated rapidly or
over long times stimulated by a ... Cited by 130 - Related articles - All 8 versions
A Lapolla, P Traldi, D Fedele - Clinical biochemistry, 2005 - Elsevier Non-enzymatic glycation products are a complex and heterogeneous group of compounds which accumulate
in plasma and tissues in diabetes and renal failure. There is emerging evidence that these compounds
may play a role in the pathogenesis ... Cited by 47 - Related articles - All 4 versions
A Lapolla, D Fedele, P Traldi - Mass spectrometry reviews, 2000 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets. In
this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the ... Cited by 43 - Related articles - BL Direct - All 8 versions
- ►sherbornegibbs.com [PDF] SF Yan, R Ramasamy, LG Bucciarelli, T … - Diabetes & Vascular …, 2004 - dvr.sagepub.com Abstract T he complications of diabetes are myriad and repre- sent a rising cause of morbidity and
mortality, par- ticularly in the Western world. The update of the Diabetes Control and Clinical
Trials Group/Epidemiology of ... Cited by 33 - Related articles - All 8 versions
DMR Rev - Diabetes Metab Res Rev, 2004 - biochemie.uni-greifswald.de Diabetes Metab Res Rev 2004; 20: 369–382. Published online 21 June 2004 in Wiley InterScience
(www.interscience.wiley.com). DOI: 10.1002/dmrr.488 ... Casper G. Schalkwijk1,4* Coen DA
Stehouwer2,4 Victor WM van ... Cited by 33 - Related articles - View as HTML - BL Direct - All 4 versions
M Fukunaga, S Miyata, BF Liu, H Miyazaki, Y Hirota … - … and Biophysical Research …, 2004 - Elsevier The formation of glucose-derived methylglyoxal (MG), a highly reactive dicarbonyl compound, is
accelerated under diabetic conditions. We examined whether MG was capable of inducing apoptosis in
Schwann cells (SCs), since recent ... Cited by 31 - Related articles - All 5 versions
- ►diabetesjournals.org P Justo, AB Sanz, J Egido, A Ortiz - Diabetes, 2005 - Am Diabetes Assoc Diabetes complications are caused by hyperglycemia. Hyperglycemia results in increased
concentrations of glucose degradation products. The study of peritoneal dialysis solution
biocompatibility has highlighted ... Cited by 31 - Related articles - BL Direct - All 5 versions
A Ortiz, A Wieslander, T Linden, B … - Current medicinal …, 2006 - ingentaconnect.com Division of Nephrology and Hypertension, Fundación Jiménez Díaz, Universidad Autonoma de Madrid.
Instituto Reina Sofía de Investigaciones Nefrológicas, Universidad San Pablo CEU, Dpt of Medical
Science, Madrid, Spain Abstract: ... Cited by 12 - Related articles - BL Direct - All 5 versions
A Pau, B Asproni, G Boatto, GE Grella, P De … - European Journal of …, 2004 - Elsevier Enzyme inhibition is a promising approach for the rational discovery of new leads in medicinal
chemistry. Target enzymes selected for rational drug design are those whose inhibition in vivo would
lead to the desired therapeutic ... Cited by 9 - Related articles - All 4 versions
WJ Huang, CW Tung, C Ho, JT Yang, ML Chen, PJ … - Renal …, 2007 - informahealthcare.com Aims. While previous studies have demonstrated that diabetic nephropathy is attributable to
glucose-derived dicarbonyl compounds, methylglyoxal (MGO)-inducing apoptosis in renal mesangial
cells, the molecular mechanism of ... Cited by 6 - Related articles - BL Direct - All 5 versions
